| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INCYTE CORP | 85,000 | 6,160,000 | 3.94% | ||
| 2 | BIOMARIN PHARMACEUTICAL INC | 75,000 | 6,186,000 | 3.96% | ||
| 3 | ALEXION PHARMACEUTIC | 45,000 | 6,265,000 | 4.01% | ||
| 4 | MASIMO CORP | 153,556 | 6,425,000 | 4.11% | ||
| 5 | PATTERSON COS INC | 142,600 | 6,635,000 | 4.24% | ||
| 6 | QUEST DIAGNOSTICS INC | 92,949 | 6,641,000 | 4.25% | ||
| 7 | SHIRE PLC | 45,150 | 7,761,000 | 4.96% | ||
| 8 | AGILENT TECHNOLOGIES INC | 250,000 | 9,963,000 | 6.37% | ||
| 9 | ST JUDE MED INC | 190,140 | 10,458,000 | 6.69% | ||
| 10 | QIAGEN NV | 475,000 | 10,612,000 | 6.79% | ||
| 11 | ABIOMED INC | 123,590 | 11,718,000 | 7.49% | ||
| 12 | INTEGRA LIFESCIENCES HLDGS CP COM NEW | 180,000 | 12,125,000 | 7.75% | ||
| 13 | IONIS PHARMACEUTICALS INC COM | 318,490 | 12,899,000 | 8.25% | ||
| 14 | NEUROCRINE BIOSCIE COM USD0.001 | 356,510 | 14,100,000 | 9.02% | ||
| 15 | MEAD JOHNSON NUTRITI | 166,370 | 14,136,000 | 9.04% | ||
| 16 | COOPER COS INC | 92,690 | 14,271,000 | 9.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-101867, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
